We are seeking an early-career Scientist to join the Cellular Resilience team to contribute to groundbreaking, early discovery research at the intersection of gene delivery and cell therapy. The successful candidate will leverage their expertise in Immune cell engineering, functional assay development, and synthetic/molecular biology to develop the next generation of cellular therapies.
Key Responsibilities:
Engineering cell lines and primary immune cells by viral and non-viral techniques
In-vitro cellular assay development with an emphasis on high-throughput readouts such as multicolor flow cytometry, plate reader, ELISA/MSD, qPCR
Analyze and interpret complex experimental data, present findings to both internal and external stakeholders
Qualifications:
BS/MS with 5+ years or PhD with 0+ years of post-graduate experience in a relevant field including (but not limited to) molecular biology, synthetic biology, Immunology, Biological/Chemical/Biomedical engineering…etc
Hands-on experience in the culture and engineering of established cell lines and primary human immune cells by viral and non-viral techniques such as lentivirus, AAV, LNP, electroporation…etc
Hands-on experience with the execution and data analysis of immune functional assays including in vitro cytotoxicity, co-cultures, proliferation, and cytokine measurement
Proactive, highly self-motivated, and thrives in a workplace where goals may shift
Preferred Qualifications:
Experience with multi-color flow cytometry experiment design, acquisition, and analysis
Experience with gene editing technologies (ie. CRISPR, TALE, Zinc Finger …etc) and evaluating gene editing outcomes (ie. Flow cytometry, qPCR, sanger sequence, NGS..etc)
As AstraZeneca continues to put patients at the forefront of our mission, we are excited for our move to Kendall Square/Cambridge in 2026. Find out more information here: Kendall Square Press Release
Ready to join us on this mission? Apply now!
Competitive remuneration and benefits apply
We offer a competitive Total Reward program including a market driven base salary, bonus and long-term incentive. We have a generous paid time off program and a comprehensive benefits package.
The annual base pay for this position ranges from $91,008.80 - $136,513.20. Our positions offer eligibility for various incentives—an opportunity to receive short-term incentive bonuses, equity-based awards for salaried roles and commissions for sales roles. Benefits offered include qualified retirement programs, paid time off (i.e., vacation, holiday, and leaves), as well as health, dental, and vision coverage in accordance with the terms of the applicable plans.
Date Posted
10-Aug-2026Closing Date
30-Aug-2026Our mission is to build an inclusive environment where equal employment opportunities are available to all applicants and employees. In furtherance of that mission, we welcome and consider applications from all qualified candidates, regardless of their protected characteristics. If you have a disability or special need that requires accommodation, please complete the corresponding section in the application form.
AstraZeneca Boston, Massachusetts, USA Office
Boston, United States, 0
AstraZeneca Cambridge, Massachusetts, USA Office
Cambridge, United States
AstraZeneca Waltham, Massachusetts, USA Office
Waltham, United States, 0
Similar Jobs
What you need to know about the Boston Tech Scene
Key Facts About Boston Tech
- Number of Tech Workers: 269,000; 9.4% of overall workforce (2024 CompTIA survey)
- Major Tech Employers: Thermo Fisher Scientific, Toast, Klaviyo, HubSpot, DraftKings
- Key Industries: Artificial intelligence, biotechnology, robotics, software, aerospace
- Funding Landscape: $15.7 billion in venture capital funding in 2024 (Pitchbook)
- Notable Investors: Summit Partners, Volition Capital, Bain Capital Ventures, MassVentures, Highland Capital Partners
- Research Centers and Universities: MIT, Harvard University, Boston College, Tufts University, Boston University, Northeastern University, Smithsonian Astrophysical Observatory, National Bureau of Economic Research, Broad Institute, Lowell Center for Space Science & Technology, National Emerging Infectious Diseases Laboratories
